Thu.Jan 20, 2022

article thumbnail

Gilead takes legal action against counterfeit HIV drug network 

pharmaphorum

US pharma giant Gilead Sciences has accused a network of unauthorised suppliers and distributors of selling more than $250 million of counterfeit versions of its HIV medications. According to the company, the defendants reportedly sold 85,247 bottles of medicine with counterfeit Gilead labelling to pharmacies over a two-year period, using falsified supply chain documentation to conceal their origin.

article thumbnail

Cyberattacks top list of 2022 health tech hazards alongside supply chain problems, damaged infusion pumps

Fierce Healthcare

Cyberattacks top list of 2022 health tech hazards alongside supply chain problems, damaged infusion pumps. rtorrence. Thu, 01/20/2022 - 15:20.

122
122
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Will new Facebook ad policy shake up clinical trial recruitment?

Outsourcing Pharma

An expert from patient solutions firm Trialbee discusses how the social media firm's recent ban on targeted advertising might impact patient recruitment.

114
114
article thumbnail

HRSA to distribute $103M to improve mental health of stressed healthcare workforce

Fierce Healthcare

HRSA to distribute $103M to improve mental health of stressed healthcare workforce. rking. Thu, 01/20/2022 - 12:23.

130
130
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Content metrics help generate compelling communication

pharmaphorum

Companies seek efficiency and speed to market during the content creation process, review and approval cycles, and thus the collective time for content to be approved for distribution, says Ian Hale, vice president of commercial content at Veeva Systems. Gathering content metrics is key to ensuring superior performance during each step. ‘’Content metrics is the collection of content data for both the industry as a benchmark and the individual company’s content performance,’’ says Ian.

article thumbnail

Fierce JPM Week: How 23andMe plans to harness its massive database to further its ambitions in drug development

Fierce Healthcare

Fierce JPM Week: How 23andMe plans to harness its massive database to further its ambitions in drug development. hlandi. Thu, 01/20/2022 - 17:06.

105
105

More Trending

article thumbnail

CVS Health and Uber Health partner on free medical transportation to reduce barriers to care

Fierce Healthcare

CVS Health and Uber Health partner on free medical transportation to reduce barriers to care. rtorrence. Thu, 01/20/2022 - 12:22.

111
111
article thumbnail

The rise, acceleration and acceptance of telehealth adoption

pharmaphorum

‘Healing at a distance’ is the literal meaning of telemedicine. According to the World Health Organization, it is defined as the use of ICT to improve patient outcomes by increasing access to care and medical information, incorporating new advancements in technology and responding and adapting to the changing health needs and contexts of societies. Within this context, it goes without saying that Covid-19 has led to a big push towards digital healthcare solutions.

98
article thumbnail

Nearly 4K people may have gotten slightly lower Pfizer COVID-19 dose at a Kaiser Permanente location

Fierce Healthcare

Nearly 4K people may have gotten slightly lower Pfizer COVID-19 dose at a Kaiser Permanente location. agliadkovskaya. Thu, 01/20/2022 - 16:22.

105
105
article thumbnail

27 drugmakers to provide generic COVID drug to low-income countries

pharmaphorum

Twenty-seven drug makers have signed onto a deal to manufacture a generic version of molnupiravir , Merck’s oral antiviral for the treatment of COVID-19. The deal will allow affordable access to the drug in 105 low- and middle-income countries (LMICs) around the world. In October, the Geneva-based Medicines Patent Pool, a United Nations-backed public health group announced a voluntary licensing agreement by which Merck would license the drug to companies that meet certain quality-assurance

FDA 75
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Nonprofits AAMC, AAHC say their April 1 merger will 'amplify' academic medicine

Fierce Healthcare

Nonprofits AAMC, AAHC say their April 1 merger will 'amplify' academic medicine. dmuoio. Thu, 01/20/2022 - 14:30.

116
116
article thumbnail

Glenmark and Lotus partner on allergic rhinitis spray 

pharmaphorum

The mission to treat people who suffer from allergic rhinitis has been given a boost as two pharma companies join forces. The Swiss subsidiary of Glenmark Pharmaceuticals and Lotus International have signed a licensing agreement whereby Glenmark will handle the manufacture and supply of Ryaltris and Lotus will take charge of commercialising the drug, subject to approval.

72
article thumbnail

Monopoly lawsuit alleges HCA intentionally diverted patients from partner ASCs to its own hospitals

Fierce Healthcare

Monopoly lawsuit alleges HCA intentionally diverted patients from partner ASCs to its own hospitals. dmuoio. Thu, 01/20/2022 - 11:41.

Hospitals 105
article thumbnail

Approval for Covishield by the UK Government

Druggist

There are many problems and disorders which can cause trouble in your sleep like. All are easy to deal with but difficult to cure. One problem that needs special attention among these is – SLEEP APNEA. With this article on sleep apnea, read on and stay glued till the end to know an eye-opener fact and health advice on how to use “Modafinil Drug for Sleep Apnea”- the right way and right choice of treatment.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Fierce JPM Week: How virtual-first plans are tackling the balance between in-person, digital care

Fierce Healthcare

Fierce JPM Week: How virtual-first plans are tackling the balance between in-person, digital care. pminemyer. Thu, 01/20/2022 - 11:22.

104
104
article thumbnail

Tech Innovations: January 2022

Outsourcing Pharma

This monthâs list of new technology, partnerships, and other announcements includes items from ObvioHealth, Datavant, HumanFirst, and other industry players.

52
article thumbnail

States ask for more guidance from HHS on when COVID-19 emergency will end

Fierce Healthcare

States ask for more guidance from HHS on when COVID-19 emergency will end. rking. Thu, 01/20/2022 - 16:52.

116
116
article thumbnail

Tech Innovations: December 2021

Outsourcing Pharma

This monthâs list of new technology, partnerships, and other announcements includes items from ObvioHealth, Datavant, HumanFirst, and other industry players.

52
article thumbnail

Chutes & Ladders—Hims & Hers taps Uber vet as CFO; UCSF appoints president, CEO

Fierce Healthcare

Chutes & Ladders—Hims & Hers taps Uber vet as CFO; UCSF appoints president, CEO. dmuoio. Thu, 01/20/2022 - 17:02.

98
article thumbnail

Beximco Pharma to manufacture molnupiravir for COVID-19

Pharma Times

The drug received conditional marketing authorisation in the UK from the MHRA in November

55
article thumbnail

Blue Shield of California adds Ginger to Wellvolution platform to expand mental health support

Fierce Healthcare

Blue Shield of California adds Ginger to Wellvolution platform to expand mental health support. hlandi. Thu, 01/20/2022 - 11:13.

81
article thumbnail

Booster vaccine jumpstarts Omicron protection

Pharma Times

Antibodies generated from only two vaccine doses offer less protection against the Omicron variant

article thumbnail

Humana's CenterWell planning to add 26 centers over the next year

Fierce Healthcare

Humana's CenterWell planning to add 26 centers over the next year. pminemyer. Thu, 01/20/2022 - 13:07.

75
article thumbnail

Fierce JPM Week: Cityblock's Ajayi on how to build from COVID's spotlight on health disparities

Fierce Healthcare

Fierce JPM Week: Cityblock's Ajayi on how to build from COVID's spotlight on health disparities. pminemyer. Thu, 01/20/2022 - 13:13.

40